[go: up one dir, main page]

NO20005732D0 - Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer - Google Patents

Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer

Info

Publication number
NO20005732D0
NO20005732D0 NO20005732A NO20005732A NO20005732D0 NO 20005732 D0 NO20005732 D0 NO 20005732D0 NO 20005732 A NO20005732 A NO 20005732A NO 20005732 A NO20005732 A NO 20005732A NO 20005732 D0 NO20005732 D0 NO 20005732D0
Authority
NO
Norway
Prior art keywords
phenylethylamines
phenylsulfonamide
useful
dopamine receptors
alkyl
Prior art date
Application number
NO20005732A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005732L (no
Inventor
Arthur Glenn Romero
Jeffrey A Leiby
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20005732L publication Critical patent/NO20005732L/no
Publication of NO20005732D0 publication Critical patent/NO20005732D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46Y being a hydrogen or a carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005732A 1998-05-14 2000-11-13 Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer NO20005732D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8549398P 1998-05-14 1998-05-14
PCT/US1999/007023 WO1999058499A1 (en) 1998-05-14 1999-05-07 Phenylsulfonamide-phenylethylamines useful as dopamine receptors

Publications (2)

Publication Number Publication Date
NO20005732L NO20005732L (no) 2000-11-13
NO20005732D0 true NO20005732D0 (no) 2000-11-13

Family

ID=22191975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005732A NO20005732D0 (no) 1998-05-14 2000-11-13 Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer

Country Status (24)

Country Link
US (1) US6103766A (pt)
EP (1) EP1077935B1 (pt)
JP (1) JP2002514623A (pt)
KR (1) KR20010043546A (pt)
CN (1) CN1152857C (pt)
AT (1) ATE253045T1 (pt)
AU (1) AU752543B2 (pt)
BR (1) BR9910405A (pt)
CA (1) CA2327345A1 (pt)
DE (1) DE69912419T2 (pt)
DK (1) DK1077935T3 (pt)
EA (1) EA002918B1 (pt)
ES (1) ES2211078T3 (pt)
HU (1) HUP0101746A3 (pt)
IL (1) IL139263A0 (pt)
NO (1) NO20005732D0 (pt)
NZ (1) NZ508152A (pt)
PL (1) PL343891A1 (pt)
PT (1) PT1077935E (pt)
SK (1) SK16242000A3 (pt)
TR (1) TR200003325T2 (pt)
TW (1) TW450954B (pt)
WO (1) WO1999058499A1 (pt)
ZA (1) ZA200005921B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2276278C (en) * 1997-02-27 2009-04-07 Takeda Chemical Industries, Ltd. Amine compounds, their production and use
EP1399137A4 (en) * 2001-05-07 2005-12-14 Smithkline Beecham Corp SULPHONAMIDES
WO2002089740A2 (en) * 2001-05-07 2002-11-14 Smithkline Beecham Corporation Sulfonamides
WO2006040176A1 (en) 2004-10-14 2006-04-20 Abbott Gmbh & Co. Kg Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
US8232426B2 (en) 2004-10-14 2012-07-31 Abbott Gmbh & Co. Kg Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
JP4904277B2 (ja) 2004-10-14 2012-03-28 アボット ゲーエムベーハー ウント カンパニー カーゲー ドーパミンd3受容体の調節に応答する障害の治療に好適な複素環化合物
DE602007012071D1 (de) * 2006-04-14 2011-03-03 Abbott Gmbh & Co Kg Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen
AR060462A1 (es) 2006-04-14 2008-06-18 Abbott Gmbh & Co Kg Compuestos de ariloxietilamina apropiados para tratar trastornos que responden a la modulacion del receptor de dopamina d3
WO2007118899A1 (en) 2006-04-19 2007-10-25 Abbott Gmbh & Co. Kg Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
MX2008013206A (es) 2006-04-19 2008-10-22 Abbott Gmbh & Co Kg Compuestos heterociclicos adecuados para el tratamiento de trastornos que responden a modulacion del receptor de serotonina 5ht6.
WO2008026046A1 (en) * 2006-08-30 2008-03-06 Pfizer Products Inc. Morpholine d3 dopamine antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
GB9402197D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Compounds
CA2205998C (en) * 1994-11-23 2002-07-16 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
ATE232850T1 (de) * 1996-05-11 2003-03-15 Smithkline Beecham Plc Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren
US5922770A (en) * 1996-07-22 1999-07-13 Novo Nordisk A/S Compounds with growth hormone releasing properties
JPH1180156A (ja) * 1997-09-04 1999-03-26 Hokuriku Seiyaku Co Ltd 1−(置換アリール)アルキル−1h−イミダゾピリジン−4−アミン誘導体

Also Published As

Publication number Publication date
EP1077935A1 (en) 2001-02-28
HUP0101746A3 (en) 2002-10-28
JP2002514623A (ja) 2002-05-21
PT1077935E (pt) 2004-03-31
EP1077935B1 (en) 2003-10-29
HK1036049A1 (en) 2001-12-21
BR9910405A (pt) 2001-01-09
WO1999058499A1 (en) 1999-11-18
NO20005732L (no) 2000-11-13
TR200003325T2 (tr) 2001-04-20
CA2327345A1 (en) 1999-11-18
KR20010043546A (ko) 2001-05-25
CN1152857C (zh) 2004-06-09
AU3741899A (en) 1999-11-29
PL343891A1 (en) 2001-09-10
DE69912419T2 (de) 2004-07-22
IL139263A0 (en) 2001-11-25
DK1077935T3 (da) 2004-02-16
EA200001184A1 (ru) 2001-04-23
ES2211078T3 (es) 2004-07-01
NZ508152A (en) 2003-03-28
DE69912419D1 (de) 2003-12-04
ZA200005921B (en) 2001-11-14
EA002918B1 (ru) 2002-10-31
ATE253045T1 (de) 2003-11-15
HUP0101746A2 (hu) 2002-03-28
SK16242000A3 (sk) 2001-06-11
US6103766A (en) 2000-08-15
CN1297431A (zh) 2001-05-30
TW450954B (en) 2001-08-21
AU752543B2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
NO20005732D0 (no) Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer
DK0923542T3 (da) Arylsubstituerede cycliske aminer som selektive dopamin-D3-ligander
NO973532L (no) 2-aminoindaner som selektive dopamin D3-ligander
PT1204654E (pt) Benzofurilpiperazinas agonistas do receptor 5-ht2c da serotonina
EA200200291A1 (ru) Производные биариловых эфиров, полезные в качестве ингибиторов обратного захвата моноамина
PE20031011A1 (es) Derivados de dihidrobenzodiazepin-2-ona-iii
YU56301A (sh) Inhibitori resorpcije monoamina za tretiranje poremećaja cns
PE20000467A1 (es) Derivado de indol util como inhibidor de serotonina
PE20020346A1 (es) Derivados de fenoxibencilamina como ssri
PE20000127A1 (es) Derivado de bencenosulfonamida
BR9908321A (pt) Composto
DE60014339D1 (de) Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
HRP20000508B1 (hr) Supstituirani 2-benzilamino-2-fenil-acetamidni spojevi
DK0664807T3 (da) Quinoxalindionderivater som EAA-antagonister
PE20021003A1 (es) Fenil-heterociclil-eteres como inhibidores selectivos de la recaptacion de serotonina (ssri)
PE20030539A1 (es) Derivados de piperazina antagonistas de los receptores de somatostatina sst1
CA2388470A1 (en) Use of carbonylamino derivatives against cns disorders
ES2182509T3 (es) Derivados de n-ariloxietilamina para el tratamiento de la depresion.
AR011542A1 (es) Un procedimiento para la preparacion de derivados de benzofenona y un procedimiento para la preparacion de 3,4-dihidroxi-4'-metil-5-nitrobenzofenona.
PE20040788A1 (es) Derivados de indol con afinidad al receptor de androgeno
DK0712406T3 (da) Kondenserende indolderivater som 5-HT4-receptorantagonister
HUP0103358A2 (hu) N-Szubsztituált aza-bicikloheptán-származékok, előállításuk és alkalmazásuk
BR9801075A (pt) Novos derivados naftil piperazina.
ES2182775T3 (es) Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application